期刊文献+

治疗的依从性、年龄、性别对胃溃疡患者使用三联7天疗法根除幽门螺杆菌治疗的影响 被引量:5

Helicobacter pylori eradication using a seven-day triple therapy in patients with gastric ulcer disease: comparative study of gastric ulcer subjects in compliance to therapy,age and gender
下载PDF
导出
摘要 目的研究胃溃疡患者使用三联7天疗法治疗幽门螺杆菌(Helicobacter pylori,H.pylori)感染的根除率,评估患者依从性、年龄、性别对于此类人群根除H.pylori治疗的影响。方法将经胃镜检查确诊为新发胃溃疡,并经活组织病理学检查明确有H.py-lori感染的1 075例患者纳入研究范围,所有入选患者均接受三联(洛赛克或耐信20 mg/次、2次/天,联合克拉霉素500 mg/次、2次/天,与阿莫西林1 000 mg/次、2次/天)7天疗法行根除H.pylori治疗,之后予以耐信或洛赛克20 mg/次、1次/天、治疗49天。所有入选患者系统治疗完成后6-8周复查胃镜。结果40-59岁与60岁以上人群的胃溃疡患者对治疗的依从性差异无显著性,而40岁以下人群对治疗的依从性较差(P〈0.05)。〈40岁、40-59岁和≥60岁胃溃疡患者的H.pylori根除率分别为61.0%、72.7%和81.9%。〈40岁与40-59岁和≥60岁患者的H.pylori根除率差异有统计学意义(P〈0.05)。不同性别胃溃疡患者的H.pylori根除率差异无显著性(P〉0.05)。结论使用三联7天疗法治疗胃溃疡患者的H.pylori感染,H.pylori的根除率较低,患者对治疗的依从性、年龄是影响胃溃疡患者H.pylori根除率的重要因素,而性别对此无影响。 Objective To observe the eradication rate of H.pylori in a gastric ulcer population uaing a seven-day triple therapy,and to evaluate the influence of compliance to therapy,age and gender on H.pylori eradication of the gastric ulcer population.Methods A series of 1 075 consecutive patients,being diagnosed as gastric ulcer disease by upper endoscopy and H.pylori infection by histological examination were included studied.All patients underwent standard triple therapy for 7 days(Losec or Nexium 20 mg bid,Clarithromycin 500 mg bid,and Amoxicillin 1 000 mg bid).Then all patients were treatment with Losec or Nexium 20 mg qd for a period of 49 days.All patients were checked endoscopy at 6~8 weeks after completion of all the treatment.Results The compliance to therapy was not different in gastric ulcer patients of 40~59 years old and ≥60 years old,but it was weak in gastric ulcer patients of〈 60 years old(P〈0.05).The total H.pylori eradication rate of gastric ulcer patients was 75.6%.The H.pylori eradication rates were 61.0%,72.7%,81.9% in gastric ulcer patients of 〈40 years old,40~59 years old and ≥60 years old.Compared with gastric ulcer patients of 40~59 years old and ≥60 years old,H.pylori eradication rate was significantly different in gastric ulcer patients of 40 years old(P〈0.05).The gender did not affect H.pylori eradication rate in the three groups(P〈0.05).Conclusion This study found a 7-day of triple therapy with amoxicillin,clarithromycin,and a proton pump inhibitor had a poor eradication rate of H.pylori infection.The compliance to therapy and age seem to affect the eradication rate of H.pylori infection of gastric ulcer.The gender did not affect H.pylori eradication rate in a gastric ulcer population.
出处 《胃肠病学和肝病学杂志》 CAS 2009年第10期958-960,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 幽门螺杆菌 三联疗法 胃溃疡 Helicobacter pylori Triple therapy Gastric ulcer
  • 相关文献

参考文献3

二级参考文献44

  • 1尹洪芳,李挺,张莹.胃肠B细胞淋巴瘤的增殖与凋亡及其与幽门螺杆菌的关系[J].北京大学学报(医学版),2004,36(4):348-352. 被引量:4
  • 2成虹,胡伏莲.北京地区幽门螺杆菌耐药情况及其变化趋势[J].中华医学杂志,2005,85(39):2754-2757. 被引量:176
  • 3[1]Marshall BJ,Goodwin CS,Warren JR,Murray R,Blincow ED,Blackbourn SJ,Phillips M,Waters TE,Sanderson CR.Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.Lancet 1988; 2:1437-1442 被引量:1
  • 4[2]Coghlan JG,Gilligan D,Humphries H,McKenna D,Dooley C,Sweeney E,Keane C,O'Morain C.Campylobacter pylori and recurrence of duodenal ulcers-a 12-month follow-up study.Lancet 1987; 2:1109-1111 被引量:1
  • 5[3]Van der Hulst RW,Rauws EA,Koycu B,Keller JJ,Bruno MJ,Tijssen JG,Tytgat GN.Prevention of ulcer recurrence after eradication of H pylori:a prospective long-term follow-up study.Gastroenterology 1997; 113:1082-1086 被引量:1
  • 6[4]Treiber G,Lambert JR.The impact of H pylori eradication on peptic ulcer healing.Am J Gastroenterol 1998; 93:1080-1084 被引量:1
  • 7[5]van Leerdam ME,Vreeburg EM,Rauws EA,Geraedts AA,Tijssen JG,Reitsma JB,Tytgat GN.Acute upper GI bleeding:did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000.Am J Gastroenterol 2003; 98:1494-1499 被引量:1
  • 8[6]Xia HH,Phung N,Altiparmak E,Berry A,Matheson M,Talley NJ.Reduction of peptic ulcer disease and H pylori infection but increase of reflux esophagitis in Western Sydney between 1990 and 1998.Dig Dis Sci 2001; 46:2716-2723 被引量:1
  • 9[7]Capurso L,Koch M,Capurso G,Koch G.Epidemiologia dell'ulcera peptica.In:Gullini S,Pazzi P:L'ulcera peptica:dall'epidemiologia alla terapia.Mosby Doyma Italia,1996 被引量:1
  • 10[8]Ford A,Delaney B,Forman D,Moayyedi P.Eradication therapy for peptic ulcer disease in H pylori positive patients.Cochrane Database Syst Rev 2004; CD003840 被引量:1

共引文献121

同被引文献44

  • 1Qin-Juan Sun, Xiao Liang, Qing Zheng, Wei-Qi Gu, WenZhong Liu, Shu-Dong Xiao, Hong Lu.Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai[J].World Journal of Gastroenterology,2010,16(40):5118-5121. 被引量:91
  • 2成虹,胡伏莲,谢勇,胡品津,王吉耀,吕农华,张建中,张桂英,周曾芬,吴克利,张玲霞,彭孝伟,戴宁,唐国都,姜葵,李岩,侯晓华,白文元,王明春,叶红军,刘玉兰,许乐.中国幽门螺杆菌耐药状况以及耐药对治疗的影响—全国多中心临床研究[J].胃肠病学,2007,12(9):525-530. 被引量:518
  • 3Lee MJ,Wang CJ,Tsai YY,Hwang JM,Lin WL,Tseng TH,Chu CY.Inhibitory Effect of12-O-Tctradecanoylphorbol-13-Acetate-Caused Tumor Promotion in Benzo[a]pyrene-InitiatedCD-1Mouse Skin by Baicalein. Nutrition and Cancer . 1999 被引量:1
  • 4Franceschi F, Zuccal G, Roccarina D, et al. Clinical effects of Heli- cobacter pylori outside the stomach [J]. Nat Rev Gastroenterol Hepa- tol, 2014, 11(4): 234-242. 被引量:1
  • 5Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance [J]. Gut, 2010,59(8): 1143-1153. 被引量:1
  • 6Ahmad N, Zakaria WIL Mohamed R. Analysis of antibiotic suscepti- bility patterns of Helicobacter pylori isolates from Malaysia [J]. Heli- cobacter, 2011, 16(1): 47-51. 被引量:1
  • 7Sierra F, Forero JD, Rey M. Ideal treatment for Helicobacter pylori: A systematic review [J]. Rev Gastroenterol Mex, 2014, 79(1): 28-49. 被引量:1
  • 8Sugimoto M, Yamaoka Y. Virulence factor gcnotypcs of hlico- bactcr pylot'/affect cure rates of eradication therapy [J]. Arch Immu- no1 Ther Exp 0Varsz), 2009,57(1): 45-56. 被引量:1
  • 9D Francesco V, Zull 11o A, Margiotta M, ct al. Sequential treatment for Hclicobactcr pylori does not share the risk factors of triple thera- py failure [J]. Aliment Pharmacol Thcr. 2004, 19(4): 40%414. 被引量:1
  • 10Yamaoka Y, Ojo O, Fujimoto S, ct al. Helicobacterpylori outer mem- brane proteins and gastroduodcnal disease [J]. Gut, 2006, 55: 775-781. 被引量:1

引证文献5

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部